References
- Herberman RB, Balch C, Bolhuis R, et al. Lymphokine-activated killer cell activity: characteristics of effector cells and their progenitors in blood and spleen. Immunol Today 1987; 8: 178–181
- Schwarz RE, Vujanovic N, Hiserodt JC. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res 1989; 49: 1441–1446
- Melder RJ, Whiteside TL, Vujanovic NL, et al. A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res 1988; 48: 3461–3469
- Heo DS, Whiteside TL, Kanbour A, Herberman RB. Role of LEU19(NKHl)-positive effector cells in mediating autologous and allogeneic tumor cell lysis in rIL2-activated cultures of lymphocytes infiltrating human ovarian tumors. J Immunol 1988; 140: 4042–4049